SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-011511
Filing Date
2022-05-09
Accepted
2022-05-09 16:07:00
Documents
15
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bioli20220509_8k.htm   iXBRL 8-K 24085
2 EXHIBIT 99.1 ex_372831.htm EX-99.1 198570
7 bls01.jpg GRAPHIC 12097
  Complete submission text file 0001437749-22-011511.txt   387518

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blfs-20220509.xsd EX-101.SCH 3600
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blfs-20220509_def.xml EX-101.DEF 11531
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE blfs-20220509_lab.xml EX-101.LAB 15413
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blfs-20220509_pre.xml EX-101.PRE 11687
9 EXTRACTED XBRL INSTANCE DOCUMENT bioli20220509_8k_htm.xml XML 2580
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

IRS No.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36362 | Film No.: 22904899
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
Office of Life Sciences